Author

Miriam Mañosa 1

1 Hospital Universitario Germans Trias i Pujol and CIBERe

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EVALUATION OF ADHERENCE TO INFLIXIMAB THERAPY IN IBD PATIENTS

Ariadna Clos, GIANCARLO CORRALES ROMERO, Fiorella Cañete, Triana Lobaton Ortega, macarena larrain, Laura Marin, Miriam Mañosa, EDUARD CABRE, Eugeni Domenech Morral

EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Chaparro Sanchez, A Garre, Maria Fernanda Guerra Veloz, J M Vázquez, M L De Castro, Eduardo Leo Carnerero, E Rodríguez, A Y Carbajo, Sabino Riestra Menéndez, I Jiménez, Xavier Calvet Calvo, Luis Bujanda, Montserrat Rivero, Fernando Gomollón, Jose Manuel Benitez, Fernando Bermejo, Noelia Alcaide, Ana Gutierrez Casbas;

RESPONSE TO CORTICOSTEROIDS IN ULCERATIVE COLITIS MAY BE RELATED TO MODULATION OF MTOR SIGNALING PATHWAY GENES BY MICRORNAS

Juan Enrique Naves, Josep Manyé, Violeta Loren, Miriam Mañosa, Ines Moret, Ana Aransay, Guillermo Bastida, Belen Beltran, EDUARD CABRE, Eugeni Domenech Morral

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago García-López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esth

THE AVAILABILITY OF INFLIXIMAB TROUGH LEVELS IN IBD PATIENTS ON MAINTENANCE THERAPY DEEPLY IMPACTS THERAPEUTIC DECISION-MAKING

Triana Lobaton Ortega, Fiorella Cañete, Aina Teniente, EDUARD CABRE, Miriam Mañosa, Eva Martinez, Eugeni Domenech Morral

RESCUE THERAPY WITH ANTI-TNF AGENTS FOR ESTABLISHED POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A MULTICENTRE, RETROSPECTIVE, NATIONWIDE STUDY

Eugeni Domenech Morral, Fiorella Cañete, Miriam Mañosa, Ramiro Cruz Gonzalez Sueyro, Sabino Riestra Menéndez, Manuel Barreiro de Acosta, Pilar Nos, Eva Iglesias Flores, Ana Gutierrez Casbas, Raquel Ríos, Luis Bujanda Fernández de Piérola, Carlos Gonzalez Muñoza, Albert Villoria, María José Casanova González, Antonio García He

ANP32E IS INVOLVED IN THE STEROID-REFRACTORY ULCERATIVE COLITIS

Violeta Loren, Juan Enrique Naves, F. Javier Carmona, EDUARD CABRE, Miriam Mañosa, Josep Manyé, Eugeni Domenech Morral

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

Item 1 - 10 / 12
1
2
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK